Olaf Van Tellingen

Netherlands Cancer Institute - Amsterdam / Netherlands

Medical and Health Sciences / Pharmacology

AD Scientific Index ID: 4963208

Nederlands Kanker Instituut

Registration, Add Profile,
Premium Membership

Print Your Certificate

Olaf Van Tellingen's MOST POPULAR ARTICLES

1-) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs AH Schinkel, JJM Smit, O van Tellingen, JH Beijnen, E Wagenaar, ... Cell 77 (4), 491-502, 1994 26371994

2-) Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins AH Schinkel, U Mayer, E Wagenaar, CAAM Mol, L Van Deemter, JJM Smit, ... Proceedings of the National Academy of Sciences 94 (8), 4028-4033, 1997 11661997

3-) Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine A Sparreboom, J Van Asperen, U Mayer, AH Schinkel, JW Smit, ... Proceedings of the National Academy of Sciences 94 (5), 2031-2035, 1997 10991997

4-) Overcoming the blood–brain tumor barrier for effective glioblastoma treatmentO Van Tellingen, B Yetkin-Arik, MC De Gooijer, P Wesseling, T Wurdinger, ...Drug Resistance Updates 19, 1-12, 20159972015

5-) Potent and Specific Inhibition of the Breast Cancer Resistance Protein Multidrug Transporter in Vitro and in Mouse Intestine by a Novel Analogue of Fumitremorgin CJD Allen, A Van Loevezijn, JM Lakhai, M Van Der Valk, O Van Tellingen, ...Molecular cancer therapeutics 1 (6), 417-425, 20029122002

ARTICLES

Add your articles